Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Luce

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Psychopharmacology Bulletin|January 1, 1995
Methods of pharmacoeconomic evaluation of new medical treatments in psychiatryD A Revicki, B R Luce
The American Journal of Managed Care|October 4, 1997
When is a cost-effectiveness claim valid? How much should the FDA care?B R Luce, A L Hillman
International Journal of Technology Assessment in Health Care|January 1, 1995
The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United StatesB R Luce, R E Brown
Journal of Community Health|January 1, 1983
Assessing the cost-effectiveness of preventionH D Banta, B R Luce
NIDA Research Monograph|December 1, 1977
The economic costs of smoking-induced illnessB R Luce, S O Schweitzer
Pharmacoeconomics|March 8, 1998
The role of government and private insurers in guiding and implementing pharmacoeconomic analysesD A Freund, B R Luce
Social Science & Medicine (1982)|August 1, 1997
Managed care pharmacy, socioeconomic assessments and drug adoption decisionsA Lyles, B R Luce, A M Rentz
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. A survey of standards and guidelines for cost-effectiveness analysis in health careA Stewart, J K Schmier, B R Luce
International Journal of Technology Assessment in Health Care|May 2, 2001
Introduction. Bayesian approaches to technology assessment and decision makingB R Luce, Y C Shih, K Claxton
Health Affairs (Project Hope)|January 1, 1996
The view from managed care pharmacyB R Luce, C A Lyles, A M Rentz
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Psychopharmacology Bulletin|January 1, 1995
Methods of pharmacoeconomic evaluation of new medical treatments in psychiatryD A Revicki, B R Luce
The American Journal of Managed Care|October 4, 1997
When is a cost-effectiveness claim valid? How much should the FDA care?B R Luce, A L Hillman
International Journal of Technology Assessment in Health Care|January 1, 1995
The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United StatesB R Luce, R E Brown
Journal of Community Health|January 1, 1983
Assessing the cost-effectiveness of preventionH D Banta, B R Luce
NIDA Research Monograph|December 1, 1977
The economic costs of smoking-induced illnessB R Luce, S O Schweitzer
Pharmacoeconomics|March 8, 1998
The role of government and private insurers in guiding and implementing pharmacoeconomic analysesD A Freund, B R Luce
Social Science & Medicine (1982)|August 1, 1997
Managed care pharmacy, socioeconomic assessments and drug adoption decisionsA Lyles, B R Luce, A M Rentz
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. A survey of standards and guidelines for cost-effectiveness analysis in health careA Stewart, J K Schmier, B R Luce
International Journal of Technology Assessment in Health Care|May 2, 2001
Introduction. Bayesian approaches to technology assessment and decision makingB R Luce, Y C Shih, K Claxton
Health Affairs (Project Hope)|January 1, 1996
The view from managed care pharmacyB R Luce, C A Lyles, A M Rentz
Pageof 4